Andreu Viader, Ph.D.

Andreu Viader is Senior Director and Head of Late Discovery at Jnana Therapeutics, where he oversees late preclinical through early clinical programs across Jnana’s pipeline. Prior to Jnana, he held discovery and translational positions at Axcella Health and Abide Therapeutics, leading teams and scientific programs in neuroscience, metabolic disease, and inflammation, and contributing to the progression of several novel assets into the clinic. Andreu has authored or co-authored over 20 scientific publications and patents. He obtained a B.A. in biochemistry from Hamilton College, a Ph.D. in neuroscience from Washington University in St. Louis, and completed postdoctoral training in chemical biology and metabolomics with Dr. Benjamin Cravatt at the Scripps Research Institute.